Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting May 17, 2018
Abeona Therapeutics Announces Appointment of Stefano Buono and Richard Van Duyne to its Board of Directors May 14, 2018
Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights May 11, 2018
Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease Apr 20, 2018
Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights Mar 16, 2018
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease Mar 15, 2018
